SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-009728
Filing Date
2020-04-24
Accepted
2020-04-24 17:00:41
Documents
5
Period of Report
2020-06-18
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10010691x1_def14a.htm DEF 14A 560757
2 logo_gritstone.jpg GRAPHIC 58026
3 nc10010691x1_proxycards01.jpg GRAPHIC 572492
4 nc10010691x1_proxycards02.jpg GRAPHIC 467282
5 sig_andrewallenmd.jpg GRAPHIC 15068
  Complete submission text file 0001140361-20-009728.txt   2093618
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38663 | Film No.: 20815864
SIC: 2836 Biological Products, (No Diagnostic Substances)